●
Earnings Feed
Filings
Companies
Insiders
Pricing
Blog
⌘
K
Login
Start Free
SAFECODE DRUG TECHNOLOGIES CORP.
|
10-K
Mar 25, 6:10 AM ET
SAFECODE DRUG TECHNOLOGIES CORP. 10-K
Loading document...
Contents
17
Item 1. Business.
Item 1A. Risk Factors
Item 1B. Unresolved Staff Comments
Item 2. Properties
Item 3. Legal Proceedings.
Item 5. Selected Financial Data.
Item 6. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Item 6A. Quantitative and Qualitative Disclosures About Market Risk.
Item 7. Financial Statements and Supplementary Data.
Item 8. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.
Item 8B. Other Information.
Item 9. Directors, Executive Officers and Corporate Governance.
Item 10. Executive Compensation.
Item 11. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
Item 12. Certain Relationships and Related Transactions, and Director Independence.
Item 13. Principal Accounting Fees and Services.
Item 14. Exhibits and Financial Statement Schedules.